Background
Six related Allstate insurance companies sued several medical practices and physicians, alleging that the defendants conspired to obtain more than $1.7 million in personal injury protection benefits through fraudulent and misleading medical claims. Allstate asserted claims under New Jersey’s Insurance Fraud Prevention Act and Anti-Racketeering Act.
The trial court dismissed the claims and ordered arbitration, reasoning that the Automobile Insurance Cost Reduction Act requires arbitration of disputes concerning recovery of PIP benefits. The Appellate Division reversed, vacated the arbitration orders, and directed the trial court to reinstate Allstate’s complaint and permit the claims to proceed in the Law Division with a jury trial.
The Court’s Holding
In a per curiam opinion, the New Jersey Supreme Court affirmed substantially for the reasons stated in Judge Robert J. Gilson’s published Appellate Division opinion. Claims brought under the Insurance Fraud Prevention Act or New Jersey RICO do not fall within AICRA’s PIP-arbitration framework.
The statutory schemes can be harmonized because PIP arbitration is designed for limited disputes over timely payment of PIP benefits, not complex insurance-fraud litigation. PIP arbitrators lack authority to grant equitable relief, and substantial questions exist about their ability to provide the broad discovery, third-party joinder, compensatory and treble damages, and attorneys’ fees contemplated by the Fraud Act and RICO. Arbitration provisions in Allstate’s regulatorily mandated Decision Point Review Plans were no broader than AICRA’s statutory arbitration provision.
Key Takeaways
- New Jersey Fraud Act and RICO claims are not subject to AICRA’s PIP-arbitration process.
- An insurer may pursue complex fraud claims and available statutory remedies in the Law Division, with the right to a jury trial.
- The court left standing the Appellate Division’s disagreement with the Third Circuit’s contrary interpretation of New Jersey law.
Why It Matters
The decision preserves a judicial forum for insurers alleging coordinated schemes to obtain PIP payments fraudulently. It prevents AICRA’s streamlined arbitration system from limiting access to remedies and procedures that the Fraud Act and RICO make available for complex civil-fraud cases.
The ruling also establishes New Jersey’s controlling interpretation of its own statutes despite contrary federal appellate authority, creating an important forum distinction for parties litigating similar insurance-fraud claims.